HORSHAM, Pa., July 28, 2016 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |||
| Date: | Thursday, August 11 | ||
| Time: | 4:30 pm Eastern Time | ||
| Toll Free: | 888-430-8691 | ||
| International: | 719-457-2664 | ||
| Passcode: | 1347868 | ||
| Webcast: | www.strataskinsciences.com | ||
| Replays, available through August 25, 2016 | |||
| Toll Free: | 877-870-5176 | ||
| International: | 858-384-5517 | ||
| Replay PIN: | 1347868 | ||
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused in the dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the MelaFind System used to assist in the identification and management of melanoma skin cancer.